New KDIGO guidelines since 2021, Lupus Nephritis is seeing lots of new therapeutics in the pipeline.
This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich:
New KDIGO guidelines since 2021, Lupus Nephritis is seeing lots of new therapeutics in the pipeline.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) February 9, 2024
✳️10 tweets #NephJC catch-up ✳️
✴️Let’s recap the 2024 KDIGO Lupus Nephritis Guidelines!@BradRovin @AyuobIsabelle @meg21212 @cellotonelli @Gordon7Craig#KDIGO2024
❣️Didn’t get to join the 🐺pack for this one, no worries we’ll help you wolf it down 🥩! pic.twitter.com/Xg8NdWdH23